| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.38 |
3e-17 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
6e-16 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
1e-13 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-08 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-07 |
| mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
3e-07 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-07 |
| mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-06 |